G GALENUS

Serial Number 75698923
602

Registration Progress

Application Filed
May 6, 1999
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: G GALENUS
Previous Owner: Galenus Mannheim GmbH
Classes: 005

Trademark Image

G GALENUS

Basic Information

Serial Number
75698923
Filing Date
May 6, 1999
Abandonment Date
January 22, 2003
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 12, 2003
Classes
005

Rights Holder

Galenus Mannheim GmbH

99
Address
SandhoferstraBe 116
D-68305 Mannheim
DE

Ownership History

Galenus Mannheim GmbH

Original Applicant
99
D-68305 Mannheim DE

Legal Representation

Attorney
Edward P Kelly

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

16 events
Date Code Type Description Documents
Apr 12, 2003 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jul 19, 2002 CNFR O FINAL REFUSAL MAILED Loading...
Apr 11, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 11, 2002 MAIL I PAPER RECEIVED Loading...
Mar 7, 2002 CNRT O NON-FINAL ACTION MAILED Loading...
Oct 11, 2001 CNRT O NON-FINAL ACTION MAILED Loading...
Sep 28, 2001 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2001 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 7, 2001 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2000 CNSL F LETTER OF SUSPENSION MAILED Loading...
Mar 13, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 3, 2000 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Mar 13, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 13, 1999 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 30, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Chemical substances for manufacturing pharmaceutical preparations for diuretic use, lipid lowering use, for the treatment of cardiovascular diseases and malfunctions, hormonal diseases and malfunctions, and metabolic diseases and malfunctions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005